In summary, our study uncovered the prognostic value of Aurora-A expression in thyroid cancer and a new carcinogenic mechanism: Aurora-A can increase PFKFB3-mediated glycolysis to activate the MAPK and AKT pathways. The gene discussed is PFKFB3; the disease is thyroid gland carcinoma.